NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY

Show other versions (1)

Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including dabigatran, rivaroxaban and apixaban) is presented from the standpoint of safety. The safety profile of the new oral anticoagulants is significantly better than vitamin K antagonists profile, but requires con...

Full description

Bibliographic Details
Main Authors: D. A. Napalkov, A. A. Sokolova
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
anticoagulants
atrial fibrillation
prevention of thromboembolism
warfarin
dabigatran
rivaroxaban
apixaban
Online Access:https://www.rpcardio.com/jour/article/view/193

Internet

https://www.rpcardio.com/jour/article/view/193

Similar Items